Şamil AKTAŞ, Alev CUMBUL, Ünal USLU, Serkan ERDENÖZ, Fahri OVALI, Serhat İMAMOĞLU, Ebru YALIN İMAMOĞLU

Possible antiapoptotic and neuroprotective effects of magnesium sulphate on retina in a preterm hypoxic-ischemic rat model

Background/aim: The effects of systemic magnesium sulfate (MgSO4) on retina in preterm hypoxic-ischemic (HI) rat model are not known. Our aim was to investigate the effects of MgSO4on retinal ganglion cell (RGC) count, retinal ganglion cell (RGC) apoptotic index, retinal vascular endothelial growth factor receptor-2 (VEGFR-2), and glial fibrillary acidic protein (GFAP) expressions in preterm HI rat model. Materials and methods: Fifteen, postnatal day (PND) 7 rat pups were divided into 3 groups: 1. Sham-operated group, 2. HI group, and 3. MgSO4 -treated HI group. The second and third groups underwent ischemia followed by exposure to hypoxia for 2 h (Vannucci model). The first and second groups received intraperitoneal saline and the third group received intraperitoneal MgSO4 . On PND 10, eyes of the pups were evaluated for RGC count, apoptotic index, VEGFR-2, and GFAP expressions. Results: In both HI and MgSO4 -treated HI group, the mean total RGC counts were found to be significantly decreased. However, the mean total RGC count in the MgSO4 -treated HI group was significantly higher than that of the HI group. The mean apoptotic index was found to be significantly increased in the HI group. Retinal VEGFR-2 and GFAP expressions were found to be significantly higher in the HI group. Conclusions: Magnesium sulfate preconditioning andtreatment in preterm HI rat model might diminish apoptosis, relatively preserve RGCs, and reduce retinal VEGFR-2 and GFAP expressions.Key words: Hypoxia-ischemia, magnesium sulfate, neuroprotection, retina

PDF

___

1. Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003. MMWR Morbidity and Mortality Weekly Report 2004; 53 (3): 57-59.
2. Kaur C, Sivakumar V, Foulds WS, Luu CD, Ling EA. Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia. Investigative Ophthalmology and Visual Science 2009; 50 (11): 5364-5374. doi:10.1167/iovs.09- 3552.
3. Hoyt CS. Brain injury and the eye. Eye (London) 2007; 21 (10): 1285-1289. doi: 10.1038/sj.eye.6702849.
4. Mallard C, Vexler ZS. modeling ıschemia in the immature brain: how translational are animal models? Stroke 2015; 46 (10): 3006-3011. doi: 10.1161/STROKEAHA.115.007776.
5. Netto CA, Sanches EF, Odorcyk F, Duran-Carabali LE, Sizonenko SV. Pregnancy as a valuable period for preventing hypoxia-ischemia brain damage. International Journal of Developmental Neuroscience 2018; 70: 12-24. doi: 10.1016/j. ijdevneu.2018.06.004.
6. Vannucci SJ, Hagberg H. Hypoxia-ischemia in the immature brain. Journal of Experimental Biology 2004; 207 (Pt 18): 3149- 3154. doi: 10.1242/jeb.01064.
7. Huang HM, Huang CC, Hung PL, Chang YC. Hypoxicischemic retinal injury in rat pups. Pediatric Research 2012; 72 (3): 224-231. doi: 10.1038/pr.2012.74.
8. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. American Journal of Pathology 2000; 156 (3): 965-976. doi: 10.1016/S0002-9440(10)64964-4.
9. Burtrum D, Silverstein FS. Excitotoxic injury stimulates glial fibrillary acidic protein mRNA expression in perinatal rat brain. Experimental Neurology 1993; 121 (1): 127-132. doi: 10.1006/exnr.1993.1078.
10. Zeevalk GD, Nicklas WJ. Evidence that the loss of the voltagedependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. Journal of Neurochemistry 1992; 59 (4): 1211- 1220. doi: 10.1111/j.1471-4159.1992.tb08430.x.
11. Çetinkaya M, Alkan T, Özyener F, Kafa İM, Kurt MA et al. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology 2011; 99 (4): 302- 310. doi: 10.1159/000320643.
12. Vannucci RC, Vannucci SJ. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Developmental Neuroscience 2005; 27 (2-4): 81-86. doi: 10.1159/000085978.
13. Türkyılmaz C, Türkyılmaz Z, Atalay Y, Söylemezoğlu F, Celasun B. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. Brain Research 2002; 955 (1-2): 133-137. doi: 10.1016/s0006-8993(02)03395-4.
14. Ichiba H, Tamai H, Negishi H, Ueda T, Kim TJ et al. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatrics International 2002; 44 (5): 505-509. doi: 10.1046/j.1442-200x.2002.01610.x.
15. Sameshima H, Ikenoue T. Long-term magnesium sulfate treatment as protection against hypoxic-ischemic brain injury in seven-day-old rats. American Journal of Obstetrics and Gynecololgy 2001; 184 (2): 185-190. doi: 10.1067/ mob.2001.108343.
16. Vannucci RC, Vannucci SJ. A model of perinatal hypoxicischemic brain damage. Annals of the New York Academy of Sciences 1997; 835: 234-249. doi: 10.1111/j.1749-6632.1997. tb48634.x.
17. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anatomical Record 1991; 231 (4): 482-497. doi: 10.1002/ar.1092310411.
18. West MJ. Introduction to stereology. Cold Spring Harbor Protocols 2012; 2012 (8). doi: 10.1101/pdb.top070623.
19. Abueid L, Uslu Ü, Cumbul A, Velioğlu Öğünç A, Ercan F et al. Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction. Anatolian Journal of Cardiology 2017; 17 (4): 269-275. doi: 10.14744/AnatolJCardiol.2016.7248.
20. McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Research 1986; 46 (8 Suppl): 4244s-4248s.
21. Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clinical Ophthalmology 2008; 2 (4): 879-889. doi: 10.2147/opth.s3361.
22. Sakamoto K, Endo K, Suzuki T, Fujimura K, Kurauchi Y et al. P2X7 receptor antagonists protect against N-methylD-aspartic acid-induced neuronal injury in the rat retina. European Journal of Pharmacology 2015; 756: 52-58. doi: 10.1016/j.ejphar.2015.03.008.
23. Golshani-Hebroni S. Mg(++) requirement for MtHK binding, and Mg(++) stabilization of mitochondrial membranes via activation of MtHK & MtCK and promotion of mitochondrial permeability transition pore closure: a hypothesis on mechanisms underlying Mg(++)’s antioxidant and cytoprotective effects. Gene 2016; 581 (1): 1-13. doi: 10.1016/j. gene.2015.12.046.
24. İmamoğlu EY, Gürsoy T, Karatekin G, Ovalı F. Effects of antenatal magnesium sulfate treatment on cerebral blood flow velocities in preterm neonates. Journal of Perinatology 2014; 34 (3): 192-196. doi: 10.1038/jp.2013.182.
25. Tanaka S, Sameshima H, Ikenoue T, Sakamoto H. Magnesium sulfate exposure increases fetal blood flow redistribution to the brain during acute non-acidemic hypoxemia in goats. Early Human Development 2006; 82 (9): 597-602. doi: 10.1016/j. earlhumdev.2005.12.006.
26. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. Journal of Neuropathology and Experimental Neurology 1999; 58 (6): 654-666. doi: 10.1097/00005072-199906000-00010.
27. Ogata N, Yamanaka R, Yamamoto C, Miyashiro M, Kimoto T et al. Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat. Current Eye Research 1998; 17 (11): 1087-1096. doi: 10.1076/ceyr.17.11.1087.5234.
28. Hirrlinger PG, Ulbricht E, Iandiev I, Reichenbach A, Pannicke T. Alterations in protein expression and membrane properties during Müller cell gliosis in a murine model of transient retinal ischemia. Neuroscience Letters 2010; 472 (1): 73-78. doi: 10.1016/j.neulet.2010.01.062.
29. Shepherd E, Salam RA, Middleton P, Makrides M, McIntyre S et al. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews. Cochrane Database System Review 2017; 8 (8): CD012077. doi: 10.1002/14651858.CD012077.pub2.
30. Galvin KA, Oorschot DE. Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat. Pediatric Research 1998; 44 (5): 740-745. doi: 10.1203/00006450-199811000-00017.
31. Greenwood K, Cox P, Mehmet H, Penrice J, Amess PN et al. Magnesium sulfate treatment after transient hypoxiaischemia in the newborn piglet does not protect against cerebral damage. Pediatric Research 2000; 48 (3): 346-350. doi: 10.1203/00006450-200009000-00014.
32. Koning G, Leverin AL, Nair S, Schwendimann L, Ek J et al. Magnesium induces preconditioning of the neonatal brain via profound mitochondrial protection. Journal of Cerebral Blood Flow and Metabolism 2019; 39 (6): 1038-1055. doi: 10.1177/0271678X17746132.